As a component of the Tuberculosis Structural Genomics Consortium, this project will focus on structural and biochemical characterization of key metabolic and biosynthetic enzymes in three broad categories. 1) We will determine the structures of several enzymes involved in energy production, given the need of the organism to adapt to metabolism of different carbon sources inside host macrophages, especially enzymes at key choice points where flux of metabolites between pathways is controlled. 2) We will determine the structures of enzymes required for biosynthesis of essential amino acids and co-factors, which are thought to be restricted in the nutrient-limiting environment of the phagosome. 3) Finally, we will determine the structures of enzymes that synthesize mycolic acids, polyketides, and other lipid components of the cell wall. Each of these pathways represents a critical vulnerability in the organism that could be exploited for future drug discovery. Our goal is not just to solve the structures of these proteins, but also to obtain co-crystal structures of complexes with inhibitors, which provides important information on active-site interactions for subsequent drug design. Hence, for most of our targets, we will perform screening of small-molecule libraries to identify inhibitors as ligands for co-crystallization. The inhibitory compounds we discover will also be useful as chemical tools of value for many other purposes, such as probing function in cell and validating essentiality by chemical knock-down. All structural and chemical data generated will be made available to the public to stimulate future drug discovery for tuberculosis.

Public Health Relevance

The protein crystal structures we propose to solve will not only contribute to our understanding of the function and role of these proteins in M. tuberculosis, but they will also provide important structural information for future drug discovery. Structures of complexes with inhibitors are needed to reveal active-site interactions for designing more potent drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI095208-04
Application #
8910614
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
2017-08-31
Budget Start
2015-09-01
Budget End
2016-08-31
Support Year
4
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Type
DUNS #
078592789
City
College Station
State
TX
Country
United States
Zip Code
77845
Rittershaus, Emily S C; Baek, Seung-Hun; Krieger, Inna V et al. (2018) A Lysine Acetyltransferase Contributes to the Metabolic Adaptation to Hypoxia in Mycobacterium tuberculosis. Cell Chem Biol 25:1495-1505.e3
Tuukkanen, Anne T; Freire, Diana; Chan, Sum et al. (2018) Structural Variability of EspG Chaperones from Mycobacterial ESX-1, ESX-3, and ESX-5 Type VII Secretion Systems. J Mol Biol :
Pham, Truc V; Murkin, Andrew S; Moynihan, Margaret M et al. (2017) Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 114:7617-7622
Balderas, Miriam A; Nguyen, Chinh T Q; Terwilliger, Austen et al. (2016) Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. Infect Immun 84:3408-3422
Diaz-Ochoa, Vladimir E; Lam, Diana; Lee, Carlin S et al. (2016) Salmonella Mitigates Oxidative Stress and Thrives in the Inflamed Gut by Evading Calprotectin-Mediated Manganese Sequestration. Cell Host Microbe 19:814-25
Lovewell, Rustin R; Sassetti, Christopher M; VanderVen, Brian C (2016) Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection. Curr Opin Microbiol 29:30-6
Cheng, Yu-Shan; Sacchettini, James C (2016) Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance. Biochemistry 55:1107-19
Bajaj, R Alexandra; Arbing, Mark A; Shin, Annie et al. (2016) Crystal structure of the toxin Msmeg_6760, the structural homolog of Mycobacterium tuberculosis Rv2035, a novel type II toxin involved in the hypoxic response. Acta Crystallogr F Struct Biol Commun 72:863-869
Wagner, Jonathan M; Chan, Sum; Evans, Timothy J et al. (2016) Structures of EccB1 and EccD1 from the core complex of the mycobacterial ESX-1 type VII secretion system. BMC Struct Biol 16:5
Huang, Hsiao-Ling; Krieger, Inna V; Parai, Maloy K et al. (2016) Mycobacterium tuberculosis Malate Synthase Structures with Fragments Reveal a Portal for Substrate/Product Exchange. J Biol Chem 291:27421-27432

Showing the most recent 10 out of 44 publications